LOW · 3.1

CVE-2023-50346

HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Certain endpoints within the application disclose detailed file information.

Vulnerability Description

HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Certain endpoints within the application disclose detailed file information.

CVSS Score

3.1

LOW

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
Attack Vector
NETWORK
Attack Complexity
HIGH
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
LOW
Integrity
NONE
Availability
NONE

Affected Products

VendorProductVersions
HcltechDryice Myxalytics5.9

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-50346?

CVE-2023-50346 is a vulnerability with a CVSS score of 3.1 (LOW). HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Certain endpoints within the application disclose detailed file information.

How severe is CVE-2023-50346?

CVE-2023-50346 has been rated LOW with a CVSS base score of 3.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-50346?

Check the references section above for vendor advisories and patch information. Affected products include: Hcltech Dryice Myxalytics.